J Cardiovasc Med (Hagerstown) 2021 May 19. Epub 2021 May 19.
Division of Nephrology, Dialysis and Renal Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milan Division of Nephrology and Dialysis, ASST Monza, Desio and San Gerardo Hospital Department of Cardiac, Thoracic, Vascular Sciences & Public Health, University of Padova, Padova Division of Cardiology, West Vicenza General Hospitals, Arzignano (Vicenza), Italy.
Cardiovascular diseases are the leading life-threatening complications in hemodialysis patients. In this scenario, both tachy-arrhythmias and brady-arrhythmias are involved with related hemodialysis and nonhemodialysis-dependent mechanisms; moreover, those arrhythmias usually occur in different time intervals before sudden cardiac death (SCD). Furthermore, current evidence shows that the presence of advanced chronic kidney disease (CKD) reduces the benefits of implantable cardioverter--defibrillators (ICDs), which increases the risk of both arrhythmic and nonarrhythmic death, especially in patients with advanced stages of heart failure. Read More